NewslettersHematopoiesis NewsOutcomes of CMML Patients Undergoing Allo-HCT Are Significantly Worse Compared to MDS—A Study of the CMWP of the EBMTBy Laurisa Dohm - November 28, 20230199Patients ≥18 years with chronic myelomonocytic leukemia and myelodysplastic syndromes undergoing hematopoietic cell transplantation reported to the EBMT registry were analyzed.[American Journal Of Hematology]Full Article